133 related articles for article (PubMed ID: 37244298)
1. Graphdiyne nanoplatforms for photothermal-ferroptosis combination therapy against glioblastoma.
Zhao LX; Gong ZQ; Zhang Q; He DL; Ge RL; Meng J; Ren H; Fan YG; Wang ZY
J Control Release; 2023 Jul; 359():12-25. PubMed ID: 37244298
[TBL] [Abstract][Full Text] [Related]
2. Iron-Based Nanovehicle Delivering Fin56 for Hyperthermia-Boosted Ferroptosis Therapy Against Osteosarcoma.
Zhang Y; Song Q; Zhang Y; Xiao J; Deng X; Xing X; Hu H; Zhang Y
Int J Nanomedicine; 2024; 19():91-107. PubMed ID: 38192634
[TBL] [Abstract][Full Text] [Related]
3. Fin56-induced ferroptosis is supported by autophagy-mediated GPX4 degradation and functions synergistically with mTOR inhibition to kill bladder cancer cells.
Sun Y; Berleth N; Wu W; Schlütermann D; Deitersen J; Stuhldreier F; Berning L; Friedrich A; Akgün S; Mendiburo MJ; Wesselborg S; Conrad M; Berndt C; Stork B
Cell Death Dis; 2021 Oct; 12(11):1028. PubMed ID: 34716292
[TBL] [Abstract][Full Text] [Related]
4. Fatostatin induces ferroptosis through inhibition of the AKT/mTORC1/GPX4 signaling pathway in glioblastoma.
Cai J; Ye Z; Hu Y; Ye L; Gao L; Wang Y; Sun Q; Tong S; Zhang S; Wu L; Yang J; Chen Q
Cell Death Dis; 2023 Mar; 14(3):211. PubMed ID: 36966152
[TBL] [Abstract][Full Text] [Related]
5. FIN56, a novel ferroptosis inducer, triggers lysosomal membrane permeabilization in a TFEB-dependent manner in glioblastoma.
Zhang X; Guo Y; Li H; Han L
J Cancer; 2021; 12(22):6610-6619. PubMed ID: 34659551
[No Abstract] [Full Text] [Related]
6. Iron oxide nanoparticles loaded with paclitaxel inhibits glioblastoma by enhancing autophagy-dependent ferroptosis pathway.
Chen H; Wen J
Eur J Pharmacol; 2022 Apr; 921():174860. PubMed ID: 35278406
[TBL] [Abstract][Full Text] [Related]
7. NF-
Zhou Y; Qian W; Li X; Wei W
Oxid Med Cell Longev; 2023; 2023():7098313. PubMed ID: 36699318
[TBL] [Abstract][Full Text] [Related]
8. Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome-Conjugated Magnetic Nanoparticles for Glioblastoma Therapy.
Li B; Chen X; Qiu W; Zhao R; Duan J; Zhang S; Pan Z; Zhao S; Guo Q; Qi Y; Wang W; Deng L; Ni S; Sang Y; Xue H; Liu H; Li G
Adv Sci (Weinh); 2022 Jun; 9(17):e2105451. PubMed ID: 35508804
[TBL] [Abstract][Full Text] [Related]
9. Biomimetic Macrophage Membrane-Camouflaged Nanoparticles Induce Ferroptosis by Promoting Mitochondrial Damage in Glioblastoma.
Cao Z; Liu X; Zhang W; Zhang K; Pan L; Zhu M; Qin H; Zou C; Wang W; Zhang C; He Y; Lin W; Zhang Y; Han D; Li M; Gu J
ACS Nano; 2023 Dec; 17(23):23746-23760. PubMed ID: 37991252
[TBL] [Abstract][Full Text] [Related]
10. Nonmetal Graphdiyne Nanozyme-Based Ferroptosis-Apoptosis Strategy for Colon Cancer Therapy.
Zhang C; Chen L; Bai Q; Wang L; Li S; Sui N; Yang D; Zhu Z
ACS Appl Mater Interfaces; 2022 Jun; 14(24):27720-27732. PubMed ID: 35674241
[TBL] [Abstract][Full Text] [Related]
11. HIF-α activation by the prolyl hydroxylase inhibitor roxadustat suppresses chemoresistant glioblastoma growth by inducing ferroptosis.
Su X; Xie Y; Zhang J; Li M; Zhang Q; Jin G; Liu F
Cell Death Dis; 2022 Oct; 13(10):861. PubMed ID: 36209275
[TBL] [Abstract][Full Text] [Related]
12. Drug Repurposing-Based Brain-Targeting Self-Assembly Nanoplatform Using Enhanced Ferroptosis against Glioblastoma.
Liang J; Li L; Tian H; Wang Z; Liu G; Duan X; Guo M; Liu J; Zhang W; Nice EC; Huang C; He W; Zhang H; Li Q
Small; 2023 Nov; 19(46):e2303073. PubMed ID: 37460404
[TBL] [Abstract][Full Text] [Related]
13. Selenoprotein P expression in glioblastoma as a regulator of ferroptosis sensitivity: preservation of GPX4 via the cycling-selenium storage.
Zheng X; Toyama T; Siu S; Kaneko T; Sugiura H; Yamashita S; Shimoda Y; Kanamori M; Arisawa K; Endo H; Saito Y
Sci Rep; 2024 Jan; 14(1):682. PubMed ID: 38182643
[TBL] [Abstract][Full Text] [Related]
14. FOXP3 promote the progression of glioblastoma via inhibiting ferroptosis mediated by linc00857/miR-1290/GPX4 axis.
Cao W; He Y; Lan J; Luo S; Sun B; Xiao C; Yu W; Zeng Z; Lei S
Cell Death Dis; 2024 Apr; 15(4):239. PubMed ID: 38561331
[TBL] [Abstract][Full Text] [Related]
15. Homotypic Membrane-Enhanced Blood-Brain Barrier Crossing and Glioblastoma Targeting for Precise Surgical Resection and Photothermal Therapy.
Zhang H; Guan S; Wei T; Wang T; Zhang J; You Y; Wang Z; Dai Z
J Am Chem Soc; 2023 Mar; 145(10):5930-5940. PubMed ID: 36867864
[TBL] [Abstract][Full Text] [Related]
16. An active-passive strategy for enhanced synergistic photothermal-ferroptosis therapy in the NIR-I/II biowindows.
Wu F; Chen H; Liu R; Suo Y; Li Q; Zhang Y; Liu H; Cheng Z; Chang Y
Biomater Sci; 2022 Feb; 10(4):1104-1112. PubMed ID: 35044388
[TBL] [Abstract][Full Text] [Related]
17. Bacteria loaded with glucose polymer and photosensitive ICG silicon-nanoparticles for glioblastoma photothermal immunotherapy.
Sun R; Liu M; Lu J; Chu B; Yang Y; Song B; Wang H; He Y
Nat Commun; 2022 Sep; 13(1):5127. PubMed ID: 36050316
[TBL] [Abstract][Full Text] [Related]
18. Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM.
Liu B; Ji Q; Cheng Y; Liu M; Zhang B; Mei Q; Liu D; Zhou S
J Nanobiotechnology; 2022 Mar; 20(1):161. PubMed ID: 35351131
[TBL] [Abstract][Full Text] [Related]
19. Versatile metal-phenolic network nanoparticles for multitargeted combination therapy and magnetic resonance tracing in glioblastoma.
Zhang Y; Xi K; Fu X; Sun H; Wang H; Yu D; Li Z; Ma Y; Liu X; Huang B; Wang J; Li G; Cui J; Li X; Ni S
Biomaterials; 2021 Nov; 278():121163. PubMed ID: 34601197
[TBL] [Abstract][Full Text] [Related]
20. Piezoelectric enhanced sulfur doped graphdiyne nanozymes for synergistic ferroptosis-apoptosis anticancer therapy.
Wang J; Chu Y; Zhao Z; Zhang C; Chen Q; Ran H; Cao Y; Wu C
J Nanobiotechnology; 2023 Sep; 21(1):311. PubMed ID: 37660123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
